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Abstract
Purpose Patellar tendinopathy causes significant mor-
bidity in professional and recreational athletes. Despite the
relevance of the problem, its causative factors remain
poorly understood. The purpose of this cross-sectional
study is to evaluate the influence of age, gender, weight,
height and impact profile on developing patellar tendin-
opathy in master track and field athletes.
Methods During the European Veterans Athletics
Championships in Poznan´ in July 2006, 174 athletes (103
men and 71 women; mean age: 53.8 (SD 11.4) years, range
35–82 years) were evaluated with the VISA-P question-
naire. A fully trained orthopaedic surgeon made a diagnosis
of patellar tendinopathy according to clinical criteria.
Results There was no effect of gender upon the presence
of patellar tendinopathy (n.s.). No significant track and
field specialty effect upon the frequency of patellar ten-
dinopathy was found on the VISA-P questionnaire scores.
There was no effect of track and field specialty on the
VISA-P score. No evidence of a statistically significant
association was found between age and VISA-P score
(n.s.). There was no statistically significant difference in
either prevalence of patellar tendinopathy or VISA-P score
between high-impact and low-impact athletes (n.s.).
Conclusion In master track and field athletes, impact
profile, weight, height, age and gender did not exert any
influence on developing patellar tendinopathy.
Keywords Patellar tendon  Tendinopathy  Athletes 
Aetiology  Sports  Injuries
Introduction
Tendon injuries account for a substantial proportion of
overuse injuries in sports [25, 26, 29]. Patellar tendinopa-
thy occurs in several sports, with jumping athletes being
the most susceptible [24]. It can severely limit or even end
an athletic career, and recovery from each episode can be
prolonged [27].
Tendon problems have been attributed to a variety of
intrinsic and extrinsic factors [10]. The aetiology of ten-
dinopathy remains unknown, and the lack of consistency in
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the published literature also reflects a lack of understand-
ing of causation [1, 5, 9, 17, 18, 28]. A genetic component
has been proposed, but no definitive data are available
[11, 12].
Aged tendons show little evidence of degeneration
[13, 14, 19, 21–23]. Normal ageing of connective tissue is
morphologically different from degeneration. Aged tissue
has a low rate of metabolism, decreased elasticity and low
tensile strength [23]. These are aetiopathogenetic theories,
and a cause–effect relation has not been shown in studies
based on hypothesis testing. The present investigation is
the second part of a previous investigation into tendinop-
athy in master track and field athletes [20]. In competing
Masters track and field athletes, no influence of age, gen-
der, weight, height or impact profile on the development of
Achilles tendinopathy was found [20].
The aim of this cross-sectional study is to evaluate the
correlation between patellar tendon problems and partici-
pation in master track and field athletics. The null
hypothesis is that, in competing master track and field
athletes, there is no influence of age, gender, weight, height
and impact profile on developing patellar tendon problems.
Materials and methods
Data were obtained during the European Veterans Athletics
Championships in Poznan´ in July 2006. Athletes reported
their best discipline, which was further categorized as
specialization in walking, in long-distance running events
(5,000 and 10,000 m), sprint events (100, 200 and 400 m)
and middle distance events (800 and 1,500 m), hurdle
events and jumping events (long jump, triple jump, high
jump and pole vault). Athletes specialized in walking and
long-distance running were pooled into a low-impact pro-
file group, and all others into a high-impact profile group.
A total of 3,008 athletes participated in the Champion-
ship, with 2,133 men and 875 women. The participants in
this study were recruited with flyers, posters and verbal
approach in the various stadia during the Championships.
The study included 174 athletes (103 men and 71
women; mean age: 53.8 (SD 11.4) years, range
35–82 years) (Table 1). A master or veteran athlete in track
and field athletics is a person older than 35 years.
Each participant was evaluated with the VISA-P ques-
tionnaire. The VISA-P questionnaire [36] was translated
into Swedish, Italian, Dutch, German, French, Spanish and
Russian by medically qualified bilingual speakers. A fully
trained orthopaedic surgeon (GG) made a diagnosis of
patellar tendinopathy according to clinical criteria [10]. All
the clinical examinations were performed by the same
orthopaedic surgeon (GG).
If the score of the VISA-P questionnaire was less than
100, subjects were examined by the fully trained ortho-
paedic surgeon to ascertain whether a diagnosis of patellar
tendinopathy was appropriate. Questionnaires were filled in
by the participants themselves with specifically trained
research assistants available if the subjects required any
help. Height and weight were measured before inclusion
into the study.
Both legs were exposed from above the knees, and the
patient examined while standing, supine and prone. The
knee was inspected for any malalignment, deformity,
obvious asymmetry in tendons size, localized thickening
and any previous scars. The patellar tendon was palpated
for tenderness, heat, thickening, nodule and crepitation.
Once the tester had elicited local tenderness by palpat-
ing the tendon at the inferior pole of the patella or in the
main body of the tendon with the knee fully extended and
the quadriceps relaxed, the knee was flexed to 90 degrees,
thus putting the tendon under tension. If tenderness over
the lower pole of the patella decreased or disappeared
altogether markedly, a diagnosis of patellar tendinopathy
was made [10]. Results were classified as tenderness
present on flexion or absent.
The Victorian Institute of Sports Assessment—Patellar
questionnaire (VISA-P) is an easily self-administered
questionnaire used to evaluate symptoms of patellar ten-
dinopathy and their effects on physical activity [36]. The
VISA-P score has already been formally cross-culturally
adapted to Swedish [6], Italian [30] and Dutch [38]. The
questionnaire assesses (a) symptoms, (b) simple tests of
function and (c) ability to play sport. Six of the eight
questions are scored on a visual analogue scale from 0 to
10 with 10 representing optimal health. The maximal VISA
score for an asymptomatic, fully performing individual is
100 points, and the theoretical minimum is 0 points. The
VISA scale has excellent short-term test–retest and inter-
tester reliability (both, r [ 0.95) as well as good short-term
(1 week) stability (r = 0.87). The VISA-P is responsive to
changes in clinical conditions [4].
The institutional ethics review board of Manchester
Metropolitan University (proposal 2005/11.08) approved
the study, and all athletes gave written informed consent to
participate in this study.
Table 1 Athletes demographics
Age (years) Height (cm) Weight (kg)
Women (means ± SD) 52.6 (9.7) 162.7 (6.4) 57.7 (6.2)
Range 36–73 149.1–179.2 44.4–75.1
Men (means ± SD) 54.6 (12.4) 174.2 (6.8) 69.5 (8.5)
Range 35–82 155.0–189.8 49.4–100




Student’s t test was used to detect group differences
(gender and impact profile) for normally distributed data
(height and weight). The sum scores of the VISA-P
questionnaires were compared between groups with either
the Mann–Whitney test (in the case of dichotomous cat-
egorical variables, e.g. gender, impact profile) or with the
Kruskal–Wallis test (for track and field specialty). Asso-
ciations between these two scores and also between each
score and age were investigated by correlation analysis.
The VISA-P score was re-coded into a Boolean variable
(true/false) to indicate the presence of patellar tendinop-
athy, a score less than 100 potentially indicated a prob-
lem. Associations between gender, impact profile and
track and field specialty were tested with the Chi-squared
test. Results are given either as mean and either standard
deviation (SD) or range. The level of statistical signifi-
cance was set at P \ 0.05.
Results
Eighty-one participants were diagnosed with patellar ten-
dinopathy. There was no effect of gender upon the presence
of patellar tendinopathy (n.s.) (Table 2).
Although patellar tendinopathy across groups seemed to
be slightly more prevalent in the sequence: walkers, long
distance runners, middle distance runners, sprinters, hur-
dlers, jumpers, no significant track and field specialty effect
upon the frequency of patellar tendinopathy was found on
the VISA-P questionnaire scores (n.s.). Equally, there was
no effect of track and field specialty on the VISA-P score
(n.s.).
There was no evidence of a statistically significant
association between age and VISA-P score (n.s.) (Fig. 1).
There was no statistically significant difference in either
prevalence of patellar tendinopathy or VISA-P score
between high-impact and low-impact athletes (n.s.)
(Table 3).
Finally, no differences were found in age, weight and
height between athletes who did or did not suffer from
patellar tendinopathy.
Discussion
The most important finding of the present study is that
impact profile, weight, height, age and gender did not
influence the development of patellar tendon problems in
master track and field athletes. The null hypothesis that, in
competing master track and field athletes, there is no
influence of age, gender, weight, height and impact profile
on developing patellar tendon problems is therefore
accepted.
One of the strengths of the present study is the use of a
validated questionnaire (VISA-P) to evaluate patellar ten-
don problems [36]. On the other hand, the division into
athletic categories made in this paper is by no means
exclusive. Many athletes train and compete in more than
one discipline. However, most athletes focus their training
for and compete in one or very few, usually related disci-
plines. Moreover, there is 95% concordance between the
self-rated best event and the event with greatest age-graded
performance [37], underlining the athletes’ inclination to
specialize. Therefore, the categorization of the different
athletic disciplines as performed in the current analysis
probably is a fair reflection of the different athletic profiles
with regard to the relative contribution of impact forces
during training and competition, but it may underestimate
these exercise-specific aspects of athletic training and
competition.
Table 2 Gender comparison
VISA-P
N Score \ 100 Score
Men 103 64 (55.7%) 91.0 (51–100)
Women 71 38 (64.4%) 90.6 (49–100)
All 174 102 (58.6%) 90.8 (49–100)
Fig. 1 Plot of age versus VISA-P score. No significant correlation
was found. The visual impression might suggest a tendency towards
less depressed scores at older ages
Table 3 Age, weight and height for the two groups (with and without
patellar tendinopathy) and associated P values of the comparisons
Age (years) Weight (kg) Height (cm)
Athletes with patellar
tendon pain
53.3 (11.0) 65.7 (10.3) 168.9 (8.3)
Athletes without patellar
tendon pain
54.4 (11.8) 63.8 (8.8) 170.0 (9.0)
P values 0.52 0.18 0.42
Values are given as mean and their standard deviation
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Another limitation of this study is that no information on
the medication taken by the athletes that may have influ-
ence on the local tendon as of the patella tendon (e.g.
nonsteroidal anti-inflammatory drugs, steroids) was avail-
able. However, there are more than 20 countries in Europe,
and more than 30 different languages spoken. Drugs have a
different trade name in different European countries, and
some drugs may be licensed in only some of these coun-
tries. It would have been unduly difficult to analyse the
information gathered.
In the present study, close to 50% of the participants had
evidence of patellar tendinopathy. Athletes taking part in a
given track or field speciality were not presenting more
frequently with patellar tendinopathy. In a prospective
study of change in patellar tendon abnormality over a
volleyball season [31], changes in tendon abnormality and
pain did not appear to be entirely dependent upon load.
Gender has been indicated as an important factor in
developing tendinopathy, and women seem to experience
less patellar tendinopathy than men [2, 3]. However, in the
present study, an association between gender and devel-
opment of patellar tendinopathy was not found.
Age is another factor that seems to predispose to tendon
problems, and the prevalence of tendon ailments seems to
increase with age in the general population [24]. However,
it is important to discriminate between increasing age
leading to (causing) intra-tendinous changes, and increas-
ing age predisposing to tendinopathy. There is good evi-
dence that tendons do not degenerate with age as such, but
a reduction in proteoglycans and an increase in crosslinks
as a tendon ages make tendons stiffer and less capable of
tolerating load [13, 14, 19, 21–23]. Thus, older people
exposed to only moderate tendon loads should not neces-
sarily have an increased risk of tendinopathy.
Body composition has recently been linked to tendin-
opathy; a greater waist circumference has been shown to
increase the prevalence of patellar tendinopathy [32]. In
addition, other studies suggest that both upper limb and
other lower limb tendinopathies increase when adipose
tissue levels increase [7, 8]. Interestingly, master athletes
seem to maintain their body composition throughout their
life span at least as long as they train and compete [33].
Also, a correlation between higher fasting plasma glucose
levels within the normoglycaemic range and rotator cuff
tears has been found [15], but not between rotator cuff tears
and lipids levels [16]. Again, master athletes have been
reported to maintain low to normal fasting glucose levels
and lipid levels at older age [34, 35]. It is therefore possible
that metabolic alterations, as reflected by blood glucose
and lipid levels and by body composition, rather than age
or gender per se, engender a risk for patellar tendinopathy.
Finally, this study did not reveal any association between
height or weight and patellar tendinopathy.
Conclusion
In the present study on study of master track and field
athletes, no influence of impact profile, weight, height, age
and gender on developing patellar tendon problems was
detected. Additional research is required to improve our
understanding of the causative factors for patellar tendon
problems in ageing athletes.
Acknowledgments Many thanks to Arndt Boshof for his valuable
support during the study. This study was organized with internal
funding from our Universities.
Conflict of interest None declared.
References
1. Ames PR, Longo UG, Denaro V, Maffulli N (2008) Achilles
tendon problems: not just an orthopaedic issue. Disabil Rehabil
30:1646–1650
2. Cook JL, Khan KM, Harcourt PR, Kiss ZS, Fehrmann MW,
Griffiths L, Wark JD (1998) Patellar tendon ultrasonography in
asymptomatic active athletes reveals hypoechoic regions: a study
of 320 tendons. Victorian Institute of Sport Tendon Study Group.
Clin J Sport Med 8:73–77
3. Cook JL, Khan KM, Kiss ZS, Griffiths L (2000) Patellar ten-
dinopathy in junior basketball players: a controlled clinical and
ultrasonographic study of 268 patellar tendons in players aged
14–18 years. Scan J Med Sci Sports 10:216–220
4. Crisp T, Khan F, Padhiar N, Morrissey D, King J, Jalan R,
Maffulli N, Frcr OC (2008) High volume ultrasound guided
injections at the interface between the patellar tendon and Hoffa’s
body are effective in chronic patellar tendinopathy: a pilot study.
Disabil Rehabil 30:1625–1634
5. Denaro V, Ruzzini L, Longo UG, Franceschi F, De Paola B,
Cittadini A, Maffulli N, Sgambato A (2010) Effect of dihydro-
testosterone on cultured human tenocytes from intact supraspi-
natus tendon. Knee Surg Sports Traumatol Arthrosc 18:971–976
6. Frohm A, Saartok T, Edman G, Renstrom P (2004) Psychometric
properties of a Swedish translation of the VISA-P outcome score
for patellar tendinopathy. BMC Musculoskelet Disord 5:49
7. Gaida JE, Alfredson L, Kiss ZS, Wilson AM, Alfredson H, Cook
JL (2009) Dyslipidemia in Achilles tendinopathy is characteristic
of insulin resistance. Med Sci Sports Exerc 41:1194–1197
8. Gaida JE, Ashe MC, Bass SL, Cook JL (2009) Is adiposity an
under-recognized risk factor for tendinopathy? A systematic
review. Arthritis Rheum 61:840–849
9. Garau G, Rittweger J, Mallarias P, Longo UG, Maffulli N (2008)
Traumatic patellar tendinopathy. Disabil Rehabil 30:1616–1620
10. Khan KM, Maffulli N, Coleman BD, Cook JL, Taunton JE (1998)
Patellar tendinopathy: some aspects of basic science and clinical
management. Br J Sports Med 32:346–355
11. Lippi G, Longo UG, Maffulli N (2010) Genetics and sports. Br
Med Bull 93:27–47
12. Longo UG, Fazio V, Poeta ML, Rabitti C, Franceschi F, Maffulli
N, Denaro V (2010) Bilateral consecutive rupture of the quadri-
ceps tendon in a man with BstUI polymorphism of the COL5A1
gene. Knee Surg Sports Traumatol Arthrosc 18:514–518
13. Longo UG, Franceschi F, Ruzzini L, Rabitti C, Morini S, Maffulli
N, Denaro V (2008) Histopathology of the supraspinatus tendon
in rotator cuff tears. Am J Sports Med 36:533–538
Knee Surg Sports Traumatol Arthrosc (2011) 19:508–512 511
123
Author's personal copy
14. Longo UG, Franceschi F, Ruzzini L, Rabitti C, Morini S, Maffulli
N, Forriol F, Denaro V (2007) Light microscopic histology of
supraspinatus tendon ruptures. Knee Surg Sports Traumatol
Arthrosc 15:1390–1394
15. Longo UG, Franceschi F, Ruzzini L, Spiezia F, Maffulli N,
Denaro V (2009) Higher fasting plasma glucose levels within the
normoglycaemic range and rotator cuff tears. Br J Sports Med
43:284–287
16. Longo UG, Franceschi F, Spiezia F, Forriol F, Maffulli N, Denaro
V (2009) Triglycerides and total serum cholesterol in rotator cuff
tears: do they matter?. Br J Sports Med PMID: 19357120
17. Longo UG, Garau G, Denaro V, Maffulli N (2008) Surgical
management of tendinopathy of biceps femoris tendon in athletes.
Disabil Rehabil 30:1602–1607
18. Longo UG, Lamberti A, Maffulli N, Denaro V (2010) Tendon
augmentation grafts: a systematic review. Br Med Bull 94:165–188
19. Longo UG, Oliva F, Denaro V, Maffulli N (2008) Oxygen species
and overuse tendinopathy in athletes. Disabil Rehabil 30:1563–1571
20. Longo UG, Rittweger J, Garau G, Radonic B, Gutwasser C,
Gilliver SF, Kusy K, Zielinski J, Felsenberg D, Maffulli N (2009)
No influence of age, gender, weight, height, and impact profile in
achilles tendinopathy in masters track and field athletes. Am J
Sports Med 37:1400–1405
21. Longo UG, Ronga M, Maffulli N (2009) Achilles tendinopathy.
Sports Med Arthrosc 17:112–126
22. Longo UG, Ronga M, Maffulli N (2009) Acute ruptures of the
achilles tendon. Sports Med Arthrosc 17:127–138
23. Maffulli N, Barrass V, Ewen SW (2000) Light microscopic his-
tology of achilles tendon ruptures. A comparison with unruptured
tendons. Am J Sports Med 28:857–863
24. Maffulli N, Kader D (2002) Tendinopathy of tendo achillis.
J Bone Joint Surg Br 84:1–8
25. Maffulli N, Longo UG, Gougoulias N, Caine D, Denaro V (2010)
Sport injuries: a review of outcomes. Br Med Bull. doi:
10.1093/bmb/ldq1026
26. Maffulli N, Longo UG, Gougoulias N, Loppini M, Denaro V
(2010) Long-term health outcomes of youth sports injuries. Br J
Sports Med 44:21–25
27. Maffulli N, Longo UG, Loppini M, Denaro V (2010) Current
treatment options for tendinopathy. Expert Opin Pharmacother
11:2177–2186
28. Maffulli N, Longo UG, Maffulli GD, Rabitti C, Khanna A, Denaro
V (2010) Marked pathological changes proximal and distal to the
site of rupture in acute Achilles tendon ruptures. Knee Surg Sports
Traumatol Arthrosc. doi:10.1007/s00167-010-1193-2
29. Maffulli N, Longo UG, Spiezia F, Denaro V (2010) Sports
injuries in young athletes: long-term outcome and prevention
strategies. Phys Sportsmed 38:29–34
30. Maffulli N, Testa V, Capasso G, Oliva F, Panni AS, Longo UG,
King JB (2008) Surgery for chronic Achilles tendinopathy pro-
duces worse results in women. Disabil Rehabil 30:1714–1720
31. Malliaras P, Cook J, Ptasznik R, Thomas S (2006) Prospective
study of change in patellar tendon abnormality on imaging and
pain over a volleyball season. Br J Sports Med 40:272–274
32. Malliaras PJ, Cook JL, Kent PM (2007) Anthropometric risk
factors for patellar tendon injury among volleyball players. Br J
Sports Med 41:259–263
33. Pollock ML, Foster C, Knapp D, Rod JL, Schmidt DH (1987)
Effect of age and training on aerobic capacity and body com-
position of master athletes. J Appl Physiol 62:725–731
34. Rogers MA, King DS, Hagberg JM, Ehsani AA, Holloszy JO
(1990) Effect of 10 days of physical inactivity on glucose toler-
ance in master athletes. J Appl Physiol 68:1833–1837
35. Seals DR, Hagberg JM, Hurley BF, Ehsani AA, Holloszy JO
(1984) Effects of endurance training on glucose tolerance and
plasma lipid levels in older men and women. Jama 252:645–649
36. Visentini PJ, Khan KM, Cook JL, Kiss ZS, Harcourt PR, Wark
JD (1998) The VISA score: an index of severity of symptoms in
patients with jumper’s knee (patellar tendinosis). Victorian
Institute of Sport Tendon Study Group. J Sci Med Sport 1:22–28
37. Wilks DC, Winwood K, Gilliver SF, Kwiet A, Chatfield M,
Michaelis I, Sun LW, Ferretti JL, Sargeant AJ, Felsenberg D,
Rittweger J (2009) Bone mass and geometry of the tibia and the
radius of master sprinters, middle and long distance runners, race-
walkers and sedentary control participants: a pQCT study. Bone
45:91–97
38. Zwerver J, Kramer T, van den Akker-Scheek I (2009) Validity
and reliability of the Dutch translation of the VISA-P question-
naire for patellar tendinopathy. BMC Musculoskelet Disord
10:102
512 Knee Surg Sports Traumatol Arthrosc (2011) 19:508–512
123
Author's personal copy
